Richard Dillon Selected Research

Richard Dillon Research Topics

Disease

13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 06/2018
12	Neoplasms (Cancer) 05/2024 - 01/2018
5	Acute Promyelocytic Leukemia 03/2024 - 01/2019
3	Infections 01/2021 - 10/2010
2	Residual Neoplasm 01/2022 - 12/2019
1	Cytokine Release Syndrome 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Necrosis 01/2022
1	Respiratory Acidosis 09/2021
1	Respiratory Insufficiency (Respiratory Failure) 09/2021
1	Lung Injury 09/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Human Influenza (Influenza) 01/2021
1	Leukemia 10/2020
1	COVID-19 01/2020
1	Fever (Fevers) 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2019
1	Frailty 06/2018
1	Anemia 01/2013
1	Iron Deficiencies 01/2012
1	Persistent Infection 10/2010
1	Hepatitis B 07/2008
1	Lymphoma (Lymphomas) 07/2008

Drug/Important Bio-Agent (IBA)

4	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2024 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2018
2	Arsenic Trioxide (Trisenox)FDA Link 03/2024 - 10/2020
2	venetoclaxIBA 03/2024 - 01/2024
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2020
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2021
2	mRNA VaccinesIBA 12/2021 - 01/2021
2	BNT162 VaccineIBA 12/2021 - 01/2021
2	VaccinesIBA 01/2021 - 01/2021
2	IronIBA 01/2013 - 01/2012
1	Azacitidine (5 Azacytidine)FDA Link 03/2024
1	CPX-351IBA 01/2023
1	Dasatinib (BMS 354825)FDA Link 01/2023
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	src-Family KinasesIBA 01/2023
1	ruxolitinibIBA 01/2022
1	InterleukinsIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	CytokinesIBA 01/2022
1	alvocidib (flavopiridol)IBA 10/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	AntibodiesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	LipidsIBA 01/2020
1	Gemtuzumab (Mylotarg)FDA Link 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2020
1	mogamulizumabIBA 12/2019
1	fms-Like Tyrosine Kinase 3IBA 10/2019
1	flt3 ligand protein (flt3 ligand)IBA 10/2019
1	AnthracyclinesIBA 01/2019
1	Saccharated Ferric Oxide (Venofer)FDA Link 01/2012
1	ferric carboxymaltoseIBA 01/2012
1	Dextrans (Dextran)FDA Link 01/2012
1	EnzymesIBA 10/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2010

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 03/2024 - 07/2008
7	Therapeutics 03/2024 - 10/2010
3	Stem Cell Transplantation 01/2021 - 12/2019
2	Aftercare (After-Treatment) 01/2012 - 10/2010
1	Induction Chemotherapy 05/2024
1	Transplantation 01/2022
1	Contraindications 09/2021
1	Artificial Respiration (Mechanical Ventilation) 09/2021
1	Extracorporeal Membrane Oxygenation 09/2021
1	Palliative Care (Palliative Therapy) 01/2020
1	Blood Transfusion (Blood Transfusions) 01/2012